These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2695169)

  • 21. Conclusions: in pursuit of an AIDS virus vaccine.
    Hilleman MR
    Immunol Ser; 1989; 44():605-20. PubMed ID: 2489125
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathogenesis of human immunodeficiency virus infection and prospects for control.
    Ho DD; Kaplan JC
    Yale J Biol Med; 1987; 60(6):589-600. PubMed ID: 3324508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From HIV infection to AIDS].
    Gluckman JC; Klatzmann D
    Nouv Rev Fr Hematol (1978); 1987; 29(1):9-12. PubMed ID: 3647357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunology of AIDS.
    Ammann AJ
    Int Ophthalmol Clin; 1989; 29(2):77-82. PubMed ID: 2654048
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunology of infection with the human immunodeficiency virus.
    Seligmann M
    Recenti Prog Med; 1988; 79(7-8):330-7. PubMed ID: 2904683
    [No Abstract]   [Full Text] [Related]  

  • 26. Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis.
    Fantuzzi L; Belardelli F; Gessani S
    J Leukoc Biol; 2003 Nov; 74(5):719-25. PubMed ID: 12960239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection of human monocytes/macrophages by HIV-1: effect on secretion of IL-1 activity.
    Roy S; Fitz-Gibbon L; Poulin L; Wainberg MA
    Immunology; 1988 Jun; 64(2):233-9. PubMed ID: 3260578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CD4-gp120 interaction and AIDS pathogenesis.
    Capon DJ; Ward RH
    Annu Rev Immunol; 1991; 9():649-78. PubMed ID: 1910691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble CD4: another therapeutic option in HIV infection.
    Lancet; 1990 May; 335(8698):1128-30. PubMed ID: 1971867
    [No Abstract]   [Full Text] [Related]  

  • 30. [Binding of HIV-1 by "soluble" CD4 receptor--new therapeutic possibilities in AIDS].
    Nowak J
    Pol Tyg Lek; 1989 Apr; 44(17):401-2. PubMed ID: 2533976
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunomodulatory effects of the HIV-1 gp120 protein on antigen presenting cells: implications for AIDS pathogenesis.
    Conti L; Fantuzzi L; Del Cornò M; Belardelli F; Gessani S
    Immunobiology; 2004; 209(1-2):99-115. PubMed ID: 15481145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complication of intramuscular/subcutaneous immune therapy in severely immune-compromised individuals.
    Picard O; Lebas J; Imbert JC; Bigel P; Zagury D
    J Acquir Immune Defic Syndr (1988); 1991; 4(6):641-3. PubMed ID: 1673716
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of mucosal immunity in development of an acquired immunodeficiency syndrome (AIDS) vaccine: workshop summary.
    Muul LM; Glass MJ; Wescott SL; Burkhardt AL; Koff WC; Strober WG
    Reg Immunol; 1989; 2(3):188-92. PubMed ID: 2701579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages.
    Lewin SR; Sonza S; Irving LB; McDonald CF; Mills J; Crowe SM
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):877-83. PubMed ID: 8798972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIDS: immunopathogenic mechanisms and research strategies.
    Fauci AS
    Clin Res; 1987 Oct; 35(6):503-10. PubMed ID: 3315396
    [No Abstract]   [Full Text] [Related]  

  • 36. Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus.
    Kazazi F; Mathijs JM; Foley P; Cunningham AL
    J Gen Virol; 1989 Oct; 70 ( Pt 10)():2661-72. PubMed ID: 2677236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic abnormalities in infants infected with human immunodeficiency virus.
    McNamara JG
    Semin Perinatol; 1989 Feb; 13(1):35-43. PubMed ID: 2645658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [AIDS vaccines: an enigma in vaccine development].
    Dorner F; Barrett N
    Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FcR-mediated enhancement of HIV-1 infection by antibody.
    Takeda A; Ennis FA
    AIDS Res Hum Retroviruses; 1990 Aug; 6(8):999-1004. PubMed ID: 2223246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.
    Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P
    Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.